Ranbaxy Laboratories, Inc.

Sun Pharmaceutical Industries Limited

Hashim Nizar Poovanathil Nagoor Meeran

Mohan Prasad

Neera Tewari

Santosh Richhariya

Yatendra Kumar

Swargam Sathyanarayana

Neera Tiwari

Nitin Maheshwari

Shantanu De

Prasenjit Prafulla Das

Sayeed Mukhtar

Dinesh Shashidharan Nair

Roshan Ramesh Medhane

Vishwesh Pravinchandra Pandya

Prabhakar Divya

Vinod George

Mohammad Rafeeq

The present disclosure provides a process for the preparation of ixazomib citrate.

Process for the preparation of ixazomib citrate

The present invention provides processes and intermediates for preparing cinacalcet base and pharmaceutically acceptable salts thereof.

Processes for the preparation of cinacalcet

The present invention provides a process for preparing novel intermediates of Formula wherein, Rcan be hydrogen, C-Calkyl, halogen, nitro, hydroxy, or C-Calkoxy; Rcan be selected from hydrophobic residue of HMG-CoA reductase inhibitors; which can be effectively used for the preparation of HMG-CoA reductase inhibitors such as rosuvastatin and pharmaceutically acceptable salts thereof. 

Intermediates for the preparation of HMG-CoA reductase inhibitors

The present invention relates to a process for the preparation of sterile doripenem.

Process for the preparation of sterile doripenem

The present invention relates to a process for the preparation of rosuvastatin calcium, a promising new HMG-CoA reductase inhibitor.

Process for the preparation of rosuvastatin

Growing community of inventors

Pathanamthitta, India

Hashim Nizar Poovanathil Nagoor Meeran